Survival Analysis of Young Leukemia Patients

EFFECT OF LONG- AND SHORT-TERM MINICONSOLIDATION ON SURVIVAL OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

A retrospective study was done on 130 AML patients treated in Shariati and Imam Hospitals in Tehran from 1991 to 1997 to investigate the value of three post-remission methods of treatment. All patients who were in complete remission (CR) (Group I) had been treated with ARA-C (300 mg/m2/day continuous infusion for 5 days) and Daunorubicine (45 mg/m2/day for 3 days) as induction and early co...

Evaluation of the survival rate and its related factors in patients with leukemia in Kurdistan Province

Background and Aim: In recent decades, the survival rates of the children with cancer have improved significantly and their five-year survival rates have reached 80%, but there are still many concerns about the survival of adolescents and young people. Methods and Materials: In this retrospective study, the data of 310 children and adults with leukemia in Kurdistan Province were extracted from...

5-year survival rate based on the types of leukemia in Iran: a Meta-analysis

Survival of Patients with Acute Lymphoblastic Leukemia

Survival in elderly acute myeloid leukemia patients.

We read with interest the paper by Pulsoni et al. on survival in unselected elderly patients. We would like to back their conclusions with a brief presentation of our data. Between 1992 and 2003, 159 non-M3 AML patients over 60 years were diagnosed and treated in our institution. 34 patients (21.9%) were treated with aggressive induction chemotherapy (daunorubicin/idarubicin + cytarabine ± etop...